Although South Africa accounts for a tiny percentage of global cannabis trade, it is an important part of the bigger picture, with cannabis markets in Europe, the UK, Israel and Australia. Cannabiz Africa reports on international developments affecting the African cannabis and hemp sector as well as consumer market trends of interest to South African operators.
Steven Hocking of the Cannabis Law Report says that for the last 15 years, governments and corporates have been working to create a regulatory scenario that champions medical cannabis and pushes back against general adult use. He joins the dots from Canberra to Casablanca, Berlin to Bangkok and beyond.
In the wake of the recent US strikes on narco-boats in the Caribbean, that most mainstream of magazines, The Economist, argues that brute force is no match for today’s high tech drug runners and a fundamental rethink is required. It proposes that the best way to hit organized crime is by taking the profit incentive out of the product and that legalizing cocaine would be such a mechanism.
The United States may be the first country to formally introduce the endo-cannabinoid system (ECS) into medical student training programmes. This comes as ongoing scientific breakthroughs in medical cannabis research expose deep gaps in the way medicine is taught at mainstream universities.
The latest report on the global cannabis industry says the market is continuing its spectacular growth trajectory, driven by growing legalization internationally and increasing demand for medical cannabis.
Guest columnist Lee Hymers takes a deep dive into the exclusionary patterns that drive global cannabis reform. Across the globe, the story is the same: regulatory systems favour a concentration of power amongst the big players to the exclusion of legacy growers, communities and entrepreneurs.
A new US study has revealed that older people drink more THC Beverages than Gen Z’ers and Millennials do. It’s also found an interesting alcohol-reduction pattern amongst cannabis drink consumers, over a third of whom are 55 years and older.
Cannabizetol (CBGD), is the latest cannabis compound discovered. According to Italian and Swiss scientists the new cannabis compound appears to have “remarkable antioxidant and skin anti-inflammatory” properties and continues to expand our knowledge of the plant.
With over 670,000 registered patients and approximately 50,000 doctors prescribing cannabis for medicinal purposes, Brazil is poised to become one of the largest producers of medicinal cannabis worldwide. However, the main obstacle to expansion is the ban on flowers and THC.
Millennials are the leading spenders on cannabis pet products, driven by their own awareness of the benefits of CBD, as well as the growing trend of owners ‘humanizing’ their pets.
A US study has shown that almost 80% of medical cannabis patients say that the cost of being part of the state-approved system is an issue. The high costs of being a legal medical patient is keeping the illicit market alive, with 10% of the study group admitting to sourcing their medical cannabis from the street.
The latest news from the rapidly evolving African cannabis and hemp sector in your in-box every Thursday, fresh and free. Don’t miss out on what’s happening on market and regulatory developments across the continent, subscribe now for exclusive coverage, breaking news and opinions that will help you make informed decisions.
"*" indicates required fields
32,400+ subscribers · Unsubscribe anytime · No spam, ever.
Start typing below to search Cannabiz Africa.
